Teduglutide

What is Teduglutide?

Teduglutide is a specialized pharmaceutical ingredient, a synthetic **glucagon-like peptide-2 (GLP-2) analog**. It's primarily used to treat **Short Bowel Syndrome (SBS)**, a severe malabsorption condition caused by significant loss of functioning small intestine. Marketed as **Gattex** (US) and **Revestive** (Europe), Teduglutide promotes intestinal healing and enhances the gut's ability to absorb nutrients and fluids, significantly improving the quality of life for SBS patients.

How Does it Work?

The action of Teduglutide mimics natural GLP-2, an intestinotrophic hormone promoting intestinal lining growth and repair. It binds to GLP-2 receptors on intestinal cells, stimulating mucosal growth, increasing villus height and crypt depth for expanded absorption. It also enhances intestinal blood flow, improves barrier function, and slows gastric emptying. These actions optimize the remaining intestine's efficiency, reducing the need for **parenteral nutrition** and intravenous fluids, thereby enhancing **intestinal adaptation** in SBS.

Medical Uses

Teduglutide is indicated for Short Bowel Syndrome (SBS) in adults and pediatric patients aged 1 year and above. SBS results from a significant small intestine loss, leading to severe malabsorption and often requiring long-term parenteral nutrition (PN), which carries substantial risks. The primary goal of Teduglutide therapy is to reduce or eliminate PN dependence by improving the remaining intestine's absorptive capacity. By promoting intestinal adaptation, it helps patients absorb more from oral or enteral intake, enhancing their quality of life. It manages SBS symptoms and improves function, but is not a cure.

Dosage

The recommended dosage of Teduglutide is 0.05 mg/kg body weight, administered once daily via subcutaneous injection. Patients must strictly follow prescription and administration instructions. The lyophilized powder requires reconstitution with sterile water. Injections are given subcutaneously into the abdomen, thigh, or upper arm, rotating sites. Avoid tender areas. Pediatric dosages are weight-based. Healthcare professionals provide training on reconstitution and injection. Missed doses should be taken when remembered, unless near the next dose. Never double a dose. Regular medical monitoring is essential.

Side Effects

Teduglutide can cause side effects. Common ones include abdominal pain, nausea, vomiting, injection site reactions, headache, fluid retention (peripheral edema), and upper respiratory tract infections. More serious effects, though less common, include intestinal obstruction, fluid overload, and heart failure. Biliary and pancreatic issues are also possible. Due to its growth-promoting effects, a theoretical risk of colon polyps or colorectal cancer exists. Therefore, colonoscopy screening is often recommended before and periodically during treatment. Report any new or worsening symptoms to a healthcare provider immediately.

Drug Interactions

Teduglutide has low potential for significant drug interactions. However, by enhancing intestinal absorption, it could alter the absorption of other orally administered medications, potentially increasing systemic exposure of certain drugs. Patients must inform their healthcare provider about all medications, including over-the-counter drugs and supplements. Close monitoring may be needed for narrow therapeutic index drugs. Caution is also advised with medications affecting fluid and electrolyte balance, such as diuretics, as Teduglutide influences fluid absorption. Always consult a doctor or pharmacist before changing medications.

FAQ

Is Teduglutide a cure for Short Bowel Syndrome (SBS)?

No, Teduglutide is not a cure for SBS. It is a long-term treatment designed to improve the function of the remaining intestine, enhance nutrient and fluid absorption, and reduce the need for parenteral nutrition (PN) and intravenous fluids. It helps the body adapt and function more effectively despite the shortened bowel.

How long do I need to take Teduglutide?

Treatment with Teduglutide is typically long-term, as directed by your healthcare provider. The goal is to sustain improved intestinal function and reduce dependence on PN. The duration of therapy will depend on individual patient response and clinical assessment.

Can children use Teduglutide?

Yes, Teduglutide is approved for use in pediatric patients aged 1 year and above who have Short Bowel Syndrome and are dependent on parenteral nutrition.

How should Teduglutide be stored?

Unopened vials of Teduglutide should be stored refrigerated at 2°C to 8°C (36°F to 46°F). Once reconstituted, the solution should be used immediately. If not used immediately, it can be stored for a short period (e.g., up to 3 hours at room temperature or 24 hours refrigerated, depending on specific product instructions) before administration, but immediate use is generally recommended.

What are the brand names for Teduglutide?

The primary brand names for Teduglutide are Gattex in the United States and Revestive in Europe and other regions.

Products containing Teduglutide are available through trusted online pharmacies. You can browse Teduglutide-based medications at ShipperVIP or Medicenter.

Summary

Teduglutide is a crucial therapeutic agent for managing Short Bowel Syndrome (SBS). As a GLP-2 analog, it actively promotes intestinal lining growth and adaptation, significantly enhancing nutrient and fluid absorption. This reduces dependence on parenteral nutrition, mitigating risks and improving quality of life for both adult and pediatric patients. While requiring daily subcutaneous administration and careful monitoring, Teduglutide's benefits in intestinal rehabilitation are substantial, empowering individuals with SBS to lead more independent lives.